|
|
|
|
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
(Address of Principal executive offices)
|
|
(Zip Code)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Exhibit No.
|
Description
|
|
Exhibit 104
|
Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.
|
SOLAREDGE TECHNOLOGIES, INC.
|
|||
Date: May 3, 2021
|
By:
|
/s/ Ronen Faier | |
Name: | Ronen Faier | ||
Title: | Chief Financial Officer |
• |
Revenues of $405.5 million
|
• |
Revenues from solar products of $376.4 million
|
• |
GAAP gross margin of 34.5%
|
• |
Non-GAAP gross margin of 36.5%
|
• |
GAAP gross margin from sale of solar products of 38.3%
|
• |
Record non-GAAP gross margin from sale of solar products of 39.7%
|
• |
GAAP net income of $30.1 million
|
• |
Non-GAAP net income of $55.5 million
|
• |
GAAP net diluted earnings per share (“EPS”) of $0.55
|
• |
Non-GAAP net diluted EPS of $0.98
|
• |
1.69 Gigawatts (AC) of inverters shipped
|
• |
Revenues to be within the range of $445 million to $465 million
|
• |
Non-GAAP gross margin expected to be within the range of 32% to 34%
|
• |
Revenues from solar products to be within the range of $405 million to $420 million
|
• |
Non-GAAP gross margin from sale of solar products expected to be within the range of 36% to 38%
|
Three months ended
March 31,
|
||||||||
2021
|
2020
|
|||||||
Unaudited
|
||||||||
Revenues
|
$
|
405,489
|
$
|
431,218
|
||||
Cost of revenues
|
265,415
|
291,910
|
||||||
Gross profit
|
140,074
|
140,008
|
||||||
Operating expenses:
|
||||||||
Research and development
|
46,977
|
36,695
|
||||||
Sales and marketing
|
26,911
|
24,253
|
||||||
General and administrative
|
19,849
|
16,185
|
||||||
Other operating expenses (income), net
|
2,209
|
(4,900
|
)
|
|||||
Total
operating expenses
|
95,946
|
72,233
|
||||||
Operating income
|
44,128
|
67,775
|
||||||
Financial expenses, net
|
6,097
|
16,605
|
||||||
Income before income taxes
|
38,031
|
51,170
|
||||||
Income taxes
|
7,955
|
8,922
|
||||||
Net income
|
$
|
30,076
|
$
|
42,248
|
March 31,
|
December 31,
|
|||||||
2021
|
2020
|
|||||||
CURRENT ASSETS:
|
||||||||
Cash and cash equivalents
|
$
|
685,157
|
$
|
827,146
|
||||
Short-term bank deposits
|
43,626
|
60,096
|
||||||
Restricted bank deposits
|
2,509
|
2,611
|
||||||
Marketable securities
|
139,079
|
143,687
|
||||||
Trade receivables, net of allowances of $3,576 and $2,886, respectively
|
271,713
|
218,706
|
||||||
Inventories, net
|
340,038
|
331,696
|
||||||
Prepaid expenses and other current assets
|
102,985
|
135,399
|
||||||
Total
current assets
|
1,585,107
|
1,719,341
|
||||||
LONG-TERM ASSETS:
|
||||||||
Marketable securities
|
294,828
|
147,434
|
||||||
Deferred tax assets, net
|
17,353
|
11,676
|
||||||
Property, plant and equipment, net
|
312,214
|
303,408
|
||||||
Operating lease right-of-use assets, net
|
39,804
|
41,600
|
||||||
Intangible assets, net
|
64,196
|
67,818
|
||||||
Goodwill
|
134,620
|
140,479
|
||||||
Other long-term assets
|
16,473
|
5,353
|
||||||
Total long-term assets
|
879,488
|
717,768
|
||||||
Total
assets
|
$
|
2,464,595
|
$
|
2,437,109
|
||||
CURRENT LIABILITIES:
|
||||||||
Trade payables, net
|
$
|
122,063
|
$
|
162,051
|
||||
Employees and payroll accruals
|
63,929
|
63,738
|
||||||
Current maturities of bank loans and accrued interest
|
16,215
|
16,894
|
||||||
Warranty obligations
|
63,443
|
62,614
|
||||||
Deferred revenues and customers advances
|
21,065
|
24,648
|
||||||
Accrued expenses and other current liabilities
|
111,011
|
106,154
|
||||||
Total
current liabilities
|
397,726
|
436,099
|
||||||
LONG-TERM LIABILITIES:
|
||||||||
Convertible senior notes, net
|
619,357
|
573,350
|
||||||
Warranty obligations
|
154,510
|
142,380
|
||||||
Deferred revenues
|
122,168
|
115,372
|
||||||
Deferred tax liabilities, net
|
-
|
8,593
|
||||||
Finance lease liabilities
|
24,918
|
26,173
|
||||||
Operating lease liabilities
|
32,667
|
35,194
|
||||||
Other long-term liabilities
|
13,325
|
14,191
|
||||||
Total
long-term liabilities
|
966,945
|
915,253
|
||||||
STOCKHOLDERS’ EQUITY:
|
||||||||
Common stock
|
5
|
5
|
||||||
Additional paid-in capital
|
595,716
|
603,891
|
||||||
Accumulated other comprehensive income (loss)
|
(6,761
|
)
|
3,857
|
|||||
Retained earnings
|
510,964
|
478,004
|
||||||
Total
stockholders’ equity
|
1,099,924
|
1,085,757
|
||||||
Total
liabilities and stockholders’ equity
|
$
|
2,464,595
|
$
|
2,437,109
|
Three months ended
March 31,
|
||||||||
2021
|
2020
|
|||||||
Cash flows provided by operating activities:
|
||||||||
Net income
|
$
|
30,076
|
$
|
42,248
|
||||
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
Depreciation of property, plant and equipment
|
6,887
|
5,004
|
||||||
Amortization of intangible assets
|
2,391
|
2,321
|
||||||
Amortization of debt discount and debt issuance costs
|
724
|
-
|
||||||
Amortization of premium and accretion of discount on available-for-marketable
securities, net
|
1,295
|
120
|
||||||
Stock-based compensation expenses
|
23,153
|
12,773
|
||||||
Deferred income taxes, net
|
(2,141
|
)
|
(2,859
|
)
|
||||
Loss from disposal of assets
|
2,147
|
6
|
||||||
Exchange rate fluctuations and other items, net
|
13,303
|
(1,018
|
)
|
|||||
Changes in assets and liabilities:
|
||||||||
Inventories, net
|
(8,376
|
)
|
(29,004
|
)
|
||||
Prepaid expenses and other assets
|
20,218
|
49,888
|
||||||
Trade receivables, net
|
(57,380
|
)
|
59,420
|
|||||
Trade payables, net
|
(39,034
|
)
|
(17,589
|
)
|
||||
Employees and payroll accruals
|
7,477
|
11,821
|
||||||
Warranty obligations
|
13,088
|
13,809
|
||||||
Deferred revenues and customers advances
|
3,615
|
(31,729
|
)
|
|||||
Other liabilities
|
6,640
|
(7,466
|
)
|
|||||
Net cash provided by operating activities
|
24,083
|
107,745
|
||||||
Cash flows from investing activities:
|
||||||||
Investment in available-for-sale marketable securities
|
(186,528
|
)
|
(31,924
|
)
|
||||
Proceed from maturities of available-for-sale marketable securities
|
40,450
|
42,333
|
||||||
Purchase of property, plant and equipment
|
(24,545
|
)
|
(27,053
|
)
|
||||
Withdrawal from (investment in) bank deposits, net
|
16,470
|
(3,316
|
)
|
|||||
Other investing activities
|
571
|
36
|
||||||
Net cash used in investing activities
|
(153,582
|
)
|
(19,924
|
)
|
||||
Cash flows from financing activities:
|
||||||||
Repayment of bank loans
|
(34
|
)
|
(15,232
|
)
|
||||
Proceeds from bank loans
|
-
|
15,295
|
||||||
Proceeds from exercise of stock-based awards net of tax withholding
|
(1,716
|
)
|
3,308
|
|||||
Other financing activities
|
(312
|
)
|
(56
|
)
|
||||
Net cash provided by (used in) financing activities
|
(2,062
|
)
|
3,315
|
|||||
Increase (decrease) in cash and cash equivalents
|
(131,561
|
)
|
91,136
|
|||||
Cash and cash equivalents at the beginning of the period
|
827,146
|
223,901
|
||||||
Effect of exchange rate differences on cash and cash equivalents
|
(10,428
|
)
|
9,035
|
|||||
Cash and cash equivalents at the end of the period
|
$
|
685,157
|
$
|
324,072
|
Reconciliation of GAAP to Non-GAAP Gross Profit
|
||||||||||||
Three months ended
|
||||||||||||
March 31, 2021
|
December 31, 2020
|
March 31, 2020
|
||||||||||
Gross profit (GAAP)
|
140,074
|
110,325
|
140,008
|
|||||||||
Revenues from finance component
|
(86
|
)
|
----
|
----
|
||||||||
Stock-based compensation
|
5,790
|
3,720
|
2,273
|
|||||||||
Cost of product adjustment
|
----
|
----
|
313
|
|||||||||
Amortization and depreciation of acquired assets
|
2,312
|
2,374
|
2,356
|
|||||||||
Gross profit (Non-GAAP)
|
148,090
|
116,419
|
144,950
|
Reconciliation of GAAP to Non-GAAP Gross Margin
|
||||||||||||
Three months ended
|
||||||||||||
March 31, 2021
|
December 31, 2020
|
March 31, 2020
|
||||||||||
Gross margin (GAAP)
|
34.5
|
%
|
30.8
|
%
|
32.5
|
%
|
||||||
Revenues from finance component
|
0.0
|
%
|
----
|
----
|
||||||||
Stock-based compensation
|
1.4
|
%
|
1.0
|
%
|
0.5
|
%
|
||||||
Cost of product adjustment
|
----
|
----
|
0.1
|
%
|
||||||||
Amortization and depreciation of acquired assets
|
0.6
|
%
|
0.7
|
%
|
0.5
|
%
|
||||||
Gross margin (Non-GAAP)
|
36.5
|
%
|
32.5
|
%
|
33.6
|
%
|
Reconciliation of GAAP to Non-GAAP Operating expenses
|
||||||||||||
Three months ended
|
||||||||||||
March 31, 2021
|
December 31, 2020
|
March 31, 2020
|
||||||||||
Operating expenses (GAAP)
|
95,946
|
95,898
|
72,233
|
|||||||||
Stock-based compensation - R&D
|
(8,798
|
)
|
(8,919
|
)
|
(5,378
|
)
|
||||||
Stock-based compensation - S&M
|
(5,435
|
)
|
(8,710
|
)
|
(3,192
|
)
|
||||||
Stock-based compensation - G&A
|
(3,130
|
)
|
(2,967
|
)
|
(1,930
|
)
|
||||||
Amortization and depreciation of acquired assets - R&D
|
(12
|
)
|
(14
|
)
|
(26
|
)
|
||||||
Amortization and depreciation of acquired assets - S&M
|
(237
|
)
|
(230
|
)
|
(295
|
)
|
||||||
Amortization and depreciation of acquired assets - G&A
|
(8
|
)
|
(8
|
)
|
(9
|
)
|
||||||
Assets sale (disposal)
|
62
|
(649
|
)
|
----
|
||||||||
Other operating income (expenses)
|
(2,209
|
)
|
(1,471
|
)
|
4,900
|
|||||||
Operating expenses (Non-GAAP)
|
76,179
|
72,930
|
66,303
|
Reconciliation of GAAP to Non-GAAP Operating income
|
||||||||||||
Three months ended
|
||||||||||||
March 31, 2021
|
December 31, 2020
|
March 31, 2020
|
||||||||||
Operating income (GAAP)
|
44,128
|
14,427
|
67,775
|
|||||||||
Revenues from finance component
|
(86
|
)
|
----
|
----
|
||||||||
Cost of product adjustment
|
----
|
----
|
313
|
|||||||||
Stock-based compensation
|
23,153
|
24,316
|
12,773
|
|||||||||
Amortization and depreciation of acquired assets
|
2,569
|
2,626
|
2,686
|
|||||||||
Assets (sale) disposal
|
(62
|
)
|
649
|
----
|
||||||||
Other operating (income) expenses
|
2,209
|
1,471
|
(4,900
|
)
|
||||||||
Operating income (Non-GAAP)
|
71,911
|
43,489
|
78,647
|
Reconciliation of GAAP to Non-GAAP
Financial expenses (income), net
|
||||||||||||
Three months ended
|
||||||||||||
March 31, 2021
|
December 31, 2020
|
March 31, 2020
|
||||||||||
Financial expenses (income), net (GAAP)
|
6,097
|
(10,380
|
)
|
16,605
|
||||||||
Notes due 2025
|
(724
|
)
|
(3,017
|
)
|
----
|
|||||||
Non cash interest
|
(1,336
|
)
|
(1,305
|
)
|
(1,128
|
)
|
||||||
Currency fluctuation related to lease standard
|
2,289
|
(2,172
|
)
|
1,033
|
||||||||
Amortization and depreciation of acquired assets
|
----
|
----
|
(982
|
)
|
||||||||
Financial expenses (income), net (Non-GAAP)
|
6,326
|
(16,874
|
)
|
15,528
|
Reconciliation of GAAP to Non-GAAP Tax on income
|
||||||||||||
Three months ended
|
||||||||||||
March 31, 2021
|
December 31, 2020
|
March 31, 2020
|
||||||||||
Tax on income (GAAP)
|
7,955
|
7,152
|
8,922
|
|||||||||
Deferred taxes
|
2,141
|
(2,522
|
)
|
3,536
|
||||||||
Tax on income (Non-GAAP)
|
10,096
|
4,630
|
12,458
|
Reconciliation of GAAP to Non-GAAP Net income
|
||||||||||||
Three months ended
|
||||||||||||
March 31, 2021
|
December 31, 2020
|
March 31, 2020
|
||||||||||
Net income (GAAP)
|
30,076
|
17,655
|
42,248
|
|||||||||
Revenues from finance component
|
(86
|
)
|
----
|
----
|
||||||||
Cost of product adjustment
|
----
|
----
|
313
|
|||||||||
Stock-based compensation
|
23,153
|
24,316
|
12,773
|
|||||||||
Amortization and depreciation of acquired assets
|
2,569
|
2,626
|
3,668
|
|||||||||
Assets (sale) disposal
|
(62
|
)
|
649
|
----
|
||||||||
Other operating (income) expenses
|
2,209
|
1,471
|
(4,900
|
)
|
||||||||
Notes due 2025
|
724
|
3,017
|
----
|
|||||||||
Non cash interest
|
1,336
|
1,305
|
1,128
|
|||||||||
Currency fluctuation related to lease standard
|
(2,289
|
)
|
2,172
|
(1,033
|
)
|
|||||||
Deferred taxes
|
(2,141
|
)
|
2,522
|
(3,536
|
)
|
|||||||
Net income (Non GAAP)
|
55,489
|
55,733
|
50,661
|
Reconciliation of GAAP to Non-GAAP Net basic EPS
|
||||||||||||
Three months ended
|
||||||||||||
March 31, 2021
|
December 31, 2020
|
March 31, 2020
|
||||||||||
Net basic earnings per share (GAAP)
|
0.58
|
0.34
|
0.86
|
|||||||||
Revenues from finance component
|
0.00
|
----
|
----
|
|||||||||
Cost of product adjustment
|
----
|
----
|
0.01
|
|||||||||
Stock-based compensation
|
0.45
|
0.48
|
0.25
|
|||||||||
Amortization and depreciation of acquired assets
|
0.05
|
0.05
|
0.08
|
|||||||||
Assets (sale) disposal
|
0.00
|
0.01
|
----
|
|||||||||
Other operating (income) expenses
|
0.04
|
0.03
|
(0.10
|
)
|
||||||||
Notes due 2025
|
0.01
|
0.06
|
----
|
|||||||||
Non cash interest
|
0.03
|
0.02
|
0.02
|
|||||||||
Currency fluctuation related to lease standard
|
(0.05
|
)
|
0.05
|
(0.02
|
)
|
|||||||
Deferred taxes
|
(0.04
|
)
|
0.05
|
(0.07
|
)
|
|||||||
Net basic earnings per share (Non-GAAP)
|
1.07
|
1.09
|
1.03
|
Reconciliation of GAAP to Non-GAAP Net diluted EPS
|
||||||||||||
Three months ended
|
||||||||||||
March 31, 2021
|
December 31, 2020
|
March 31, 2020
|
||||||||||
Net diluted earnings per share (GAAP)
|
0.55
|
0.33
|
0.81
|
|||||||||
Revenues from finance component
|
0.00
|
----
|
----
|
|||||||||
Cost of product adjustment
|
----
|
----
|
0.01
|
|||||||||
Stock-based compensation
|
0.40
|
0.44
|
0.21
|
|||||||||
Amortization and depreciation of acquired assets
|
0.04
|
0.05
|
0.07
|
|||||||||
Assets (sale) disposal
|
0.00
|
0.01
|
----
|
|||||||||
Other operating (income) expenses
|
0.04
|
0.03
|
(0.09
|
)
|
||||||||
Notes due 2025
|
0.00
|
0.02
|
----
|
|||||||||
Non cash interest
|
0.03
|
0.02
|
0.02
|
|||||||||
Currency fluctuation related to lease standard
|
(0.04
|
)
|
0.04
|
(0.02
|
)
|
|||||||
Deferred taxes
|
(0.04
|
)
|
0.04
|
(0.06
|
)
|
|||||||
Net diluted earnings per share (Non-GAAP)
|
0.98
|
0.98
|
0.95
|
Reconciliation of GAAP to Non-GAAP
No. of shares used in Net diluted EPS
|
||||||||||||
Three months ended
|
||||||||||||
March 31, 2021
|
December 31, 2020
|
March 31, 2020
|
||||||||||
Number of shares used in computing net diluted earnings per share (GAAP)
|
55,997,136
|
53,496,384
|
52,172,720
|
|||||||||
Stock-based compensation
|
766,187
|
865,179
|
1,399,732
|
|||||||||
Notes due 2025
|
----
|
2,276,818
|
----
|
|||||||||
Number of shares used in computing net diluted earnings per share (Non-GAAP)
|
56,763,323
|
56,638,381
|
53,572,452
|